BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22713449)

  • 1. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series.
    Aubut N; Alain J; Claveau J
    J Cutan Med Surg; 2012; 16(3):212-7. PubMed ID: 22713449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
    Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
    J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.
    Nofal A; Alakad R; Wahid R; Hoseiny HAM
    Arch Dermatol Res; 2024 Jun; 316(7):400. PubMed ID: 38878177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
    Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
    Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.
    Moss M; Weber E; Hoverson K; Montemarano AD
    Dermatol Surg; 2019 Jul; 45(7):877-883. PubMed ID: 30608293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional methotrexate for the treatment of keratoacanthoma: retrospective study and review of the korean literature.
    Yoo MG; Kim IH
    Ann Dermatol; 2014 Apr; 26(2):172-6. PubMed ID: 24882970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eruptive Keratoacanthomas in a Red Tattoo.
    Linares-Gonzalez L; Ródenas-Herranz T; Galvez-Moreno M; Ruiz-Villaverde R
    Sultan Qaboos Univ Med J; 2020 Aug; 20(3):e372-e373. PubMed ID: 33110656
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of keratoacanthoma: Is intralesional methotrexate an option?
    Patel NP; Cervino AL
    Can J Plast Surg; 2011; 19(2):e15-8. PubMed ID: 22654538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate treatment for sarcoid-associated panuveitis.
    Dev S; McCallum RM; Jaffe GJ
    Ophthalmology; 1999 Jan; 106(1):111-8. PubMed ID: 9917790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primary cutaneous CD30+ anaplastic large cell lymphoma with intralesional methotrexate.
    Blume JE; Stoll HL; Cheney RT
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S229-30. PubMed ID: 16631947
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
    Doerfler L; Hanke CW
    J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solitary Large Keratoacanthomas of the Head and Neck: An Observational Study.
    Rossi AM; Park B; Qi B; Lee EH; Busam KJ; Nehal KS
    Dermatol Surg; 2017 Jun; 43(6):810-816. PubMed ID: 28296794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of intralesional methotrexate in specific cutaneous involvement of B-cell chronic lymphocytic leukaemia.
    Anyfantakis V; Dammak A; Wierzbicka-Hainaut E; Camus M; Osdoit S; Levilain P; Guillet G
    J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):856. PubMed ID: 19943835
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report.
    de Visscher JG; van der Wal KG; Blanken R; Willemse F
    J Oral Maxillofac Surg; 2002 Jan; 60(1):93-5. PubMed ID: 11757016
    [No Abstract]   [Full Text] [Related]  

  • 15. Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip.
    Spieth K; Gille J; Kaufmann R
    Dermatology; 2000; 200(4):317-9. PubMed ID: 10894963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional methotrexate for keratoacanthoma of the nose.
    Cohen PR; Schulze KE; Teller CF; Nelson BR
    Skinmed; 2005; 4(6):393-5. PubMed ID: 16276163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Intralesional Methotrexate in the Treatment of a Large Keratoacanthoma of the Dorsal Hand in a 99-Year-Old Woman.
    Della Valle V; Milani M
    Case Rep Dermatol; 2018; 10(3):247-250. PubMed ID: 30519171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of keratoacanthomas with intralesional methotrexate.
    Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: a comparative cohort study.
    Salido-Vallejo R; Cuevas-Asencio I; Garnacho-Sucedo G; González-Menchen A; Alcántara-Reifs C; De la Corte-Sánchez S; Vélez A; Moreno-Giménez JC
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1120-4. PubMed ID: 26369617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.